Menu
Subscribe to our Email Alerts
About Us
Island at a glance
Board
Key Management
Scientific Advisory Board
Collaborations
Science
About ISLA-101
Scientific Publications
Drug repurposing and benefits
Disease and drug terms explained
Investor Centre
Investor Welcome
Clinical programme
ASX Announcements
Presentations
Prospectus
Financial Reports
Share Price Information
Shareholder Services
Investor Fact Sheet
Corporate Governance
Corporate Directory
International Investors
Research Coverage
AGM
Media
News
IslandWatch Newsletter
Contact
Contact Us
Subscribe for Email Alerts
Media
Media
>
News
News
IslandWatch Newsletter
News
Filter by Year:
2024
2023
2022
2021
2020
12-Jun-2024
CEO Dr David Foster joins Sharewise Webinar
6-Jun-2024
ASX Briefs Podcast: Combating Mosquito-Borne Diseases
3-Jun-2024
BioPharmaDispatch: Island Pharmaceuticals announces new modelling data
8-May-2024
The Australian: Island Pharma gets much-needed cash for trial
8-May-2024
Grant to directly support ISLA-101 Phase 2a trial
19-Apr-2024
Island Pharmaceuticals CEO: ISLA-101 Shows Promise in Dengue Fever Fight, Phase 2a next
17-Apr-2024
Island CEO David Foster speaks with Stockhead on drug repurposing
16-Apr-2024
Island Pharmaceuticals advances dengue fever treatment with promising ISLA-101 study results
27-Feb-2024
Island Pharmaceuticals to raise $1.95 million for ISLA-101 development
26-Feb-2024
Island Pharmaceuticals targets $1.95 million in new capital raise
Previous
1
2
3
Next
.png){kind=logo}
